C07K 14/4737
C-reactive protein
Official title: {C-reactive protein}
C07K14/4737 (C-reactive protein) appears on 33 US grants and 34 published applications in this corpus.
Search patents in C07K- Granted patents
- 33
- Published applications
- 34
- Assignees
- 27
- Inventors
- 103
- Latest grant
- 18 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 4 |
| 2003 | 1 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 1 | 4 |
| 2012 | 0 | 2 |
| 2013 | 1 | 1 |
| 2014 | 3 | 0 |
| 2015 | 0 | 2 |
| 2016 | 2 | 4 |
| 2017 | 0 | 1 |
| 2018 | 3 | 3 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 2 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods of prognosis and treatment18 Feb 2025US 12,228,579 B2MeMed Diagnostics Ltd.
- CRP capture/detection of gram positive bacteria8 Aug 2023US 11,718,651 B2President and Fellows of Harvard College
- Methods of prognosis and treatment12 Jul 2022US 11,385,241 B2MeMed Diagnostics Ltd.
- CRP capture/detection of gram positive bacteria15 Jun 2021US 11,034,744 B2President and Fellows of Harvard College
- TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof2 Feb 2021US 10,907,138 B2Alma Mater Studiorum - Università di Bologna
- Target gene expression control system comprising dxCas9 and CRP derivative and preparation method therefor23 Jan 2025US 2025/0027095 A1
- Recombinant c-reactive protein9 Feb 2023US 2023/0039528 A1Toyobo Co., Ltd.
- Methods of prognosis and treatment13 Oct 2022US 2022/0326256 A1MeMed Diagnostics Ltd.
- Crp capture/detection of gram positive bacteria9 Sep 2021US 2021/0277079 A1President and Fellows of Harvard College
- TATk-CDKL5 Fusion Proteins, Compositions, Formulations, And Use Thereof25 Jun 2020US 2020/0199549 A1Alma Mater Studiorum - Università di Bologna
Most cited
By later US patents
- Mutant protein and methods and materials for making and using it33US 5,874,238 AImmtech International Inc. · 1999
- C-reactive protein fragment with immunomodulatory activity31US 5,783,179 ASyntex (U.S.A.) Inc. · 1998
- Method of treating non-streptococcal bacterial infections29US 5,405,832 AImmtech International Inc. · 1995
- Method of treating viral infections25US 5,585,349 AImmtech International Inc. · 1996
- Mutant protein and methods and materials for making and using it23US 6,703,219 B1Immtech International Inc. · 2004